Metabolic Dysfunction-Associated Steatohepatitis (MASH) Study

Now Enrolling Adults Ages 18 to 80

Now Enrolling

About this research study

Metabolic dysfunction-associated steatohepatitis (MASH) is the more serious form of metabolic dysfunction-associated steatotic liver disease  (MASLD) which causes the liver to swell and become damaged. Not all patients with steatosis will progress to MASH and there are currently no clear criteria to identify these patients. There are currently no approved medications for the treatment of MASH.

Velocity is enrolling people with the following risk factors for MASH for a clinical trial: known fatty liver, known diagnosis of MASH, high blood pressure, high triglycerides, overweight, type 2 diabetes.

Eligible participants...

  • Must be ages 18 to 80 years <Or age of currently enrolling cohort>> 
  • Must NOT have a history of chronic liver disease other than MASLD or MASH 
  • May receive compensation for study-related time 
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate you can decide if the study is right for you.

Enter your info

Study Locations

Van Nuys, California • Velocity Clinical Research

15211 Vanowen Street, Suite 100, Van Nuys, CA 91405
Phone: (818) 532-6880

Rockville, Maryland • Velocity Clinical Research

1201 Seven Locks Road, Suite 214, Rockville, MD 20854
Phone: (240) 698-2800

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy